Medical Care

Global Sickle Cell Disease Diagnosis and Treatment Market Research Report 2025

The global market for Sickle Cell Disease Diagnosis and Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sickle Cell Disease Diagnosis and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sickle Cell Disease Diagnosis and Treatment.
The Sickle Cell Disease Diagnosis and Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sickle Cell Disease Diagnosis and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sickle Cell Disease Diagnosis and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Emmaus Medical
Addmedica
Gamida Cell
GlycoMimetics
Pfizer
Novartis
Global Blood Therapeutics
Micelle BioPharma
Bluebird Bio
Prolong Pharmaceuticals
Modus Therapeutics
Sangamo Biosciences
Bioverativ
Imara
Ironwood Pharmaceuticals
Segment by Type
Diagnosis
Treatment
Segment by Application
Child
Adult
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sickle Cell Disease Diagnosis and Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Sickle Cell Disease Diagnosis and Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Child
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Disease Diagnosis and Treatment Market Perspective (2020-2031)
2.2 Global Sickle Cell Disease Diagnosis and Treatment Growth Trends by Region
2.2.1 Global Sickle Cell Disease Diagnosis and Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sickle Cell Disease Diagnosis and Treatment Historic Market Size by Region (2020-2025)
2.2.3 Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Region (2026-2031)
2.3 Sickle Cell Disease Diagnosis and Treatment Market Dynamics
2.3.1 Sickle Cell Disease Diagnosis and Treatment Industry Trends
2.3.2 Sickle Cell Disease Diagnosis and Treatment Market Drivers
2.3.3 Sickle Cell Disease Diagnosis and Treatment Market Challenges
2.3.4 Sickle Cell Disease Diagnosis and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Disease Diagnosis and Treatment Players by Revenue
3.1.1 Global Top Sickle Cell Disease Diagnosis and Treatment Players by Revenue (2020-2025)
3.1.2 Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Sickle Cell Disease Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sickle Cell Disease Diagnosis and Treatment Revenue
3.4 Global Sickle Cell Disease Diagnosis and Treatment Market Concentration Ratio
3.4.1 Global Sickle Cell Disease Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Disease Diagnosis and Treatment Revenue in 2024
3.5 Global Key Players of Sickle Cell Disease Diagnosis and Treatment Head office and Area Served
3.6 Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Product and Application
3.7 Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Disease Diagnosis and Treatment Breakdown Data by Type
4.1 Global Sickle Cell Disease Diagnosis and Treatment Historic Market Size by Type (2020-2025)
4.2 Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Type (2026-2031)
5 Sickle Cell Disease Diagnosis and Treatment Breakdown Data by Application
5.1 Global Sickle Cell Disease Diagnosis and Treatment Historic Market Size by Application (2020-2025)
5.2 Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sickle Cell Disease Diagnosis and Treatment Market Size (2020-2031)
6.2 North America Sickle Cell Disease Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025)
6.4 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sickle Cell Disease Diagnosis and Treatment Market Size (2020-2031)
7.2 Europe Sickle Cell Disease Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025)
7.4 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size (2020-2031)
8.2 Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sickle Cell Disease Diagnosis and Treatment Market Size (2020-2031)
9.2 Latin America Sickle Cell Disease Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025)
9.4 Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size (2020-2031)
10.2 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emmaus Medical
11.1.1 Emmaus Medical Company Details
11.1.2 Emmaus Medical Business Overview
11.1.3 Emmaus Medical Sickle Cell Disease Diagnosis and Treatment Introduction
11.1.4 Emmaus Medical Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
11.1.5 Emmaus Medical Recent Development
11.2 Addmedica
11.2.1 Addmedica Company Details
11.2.2 Addmedica Business Overview
11.2.3 Addmedica Sickle Cell Disease Diagnosis and Treatment Introduction
11.2.4 Addmedica Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
11.2.5 Addmedica Recent Development
11.3 Gamida Cell
11.3.1 Gamida Cell Company Details
11.3.2 Gamida Cell Business Overview
11.3.3 Gamida Cell Sickle Cell Disease Diagnosis and Treatment Introduction
11.3.4 Gamida Cell Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
11.3.5 Gamida Cell Recent Development
11.4 GlycoMimetics
11.4.1 GlycoMimetics Company Details
11.4.2 GlycoMimetics Business Overview
11.4.3 GlycoMimetics Sickle Cell Disease Diagnosis and Treatment Introduction
11.4.4 GlycoMimetics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
11.4.5 GlycoMimetics Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Sickle Cell Disease Diagnosis and Treatment Introduction
11.5.4 Pfizer Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Sickle Cell Disease Diagnosis and Treatment Introduction
11.6.4 Novartis Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Global Blood Therapeutics
11.7.1 Global Blood Therapeutics Company Details
11.7.2 Global Blood Therapeutics Business Overview
11.7.3 Global Blood Therapeutics Sickle Cell Disease Diagnosis and Treatment Introduction
11.7.4 Global Blood Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
11.7.5 Global Blood Therapeutics Recent Development
11.8 Micelle BioPharma
11.8.1 Micelle BioPharma Company Details
11.8.2 Micelle BioPharma Business Overview
11.8.3 Micelle BioPharma Sickle Cell Disease Diagnosis and Treatment Introduction
11.8.4 Micelle BioPharma Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
11.8.5 Micelle BioPharma Recent Development
11.9 Bluebird Bio
11.9.1 Bluebird Bio Company Details
11.9.2 Bluebird Bio Business Overview
11.9.3 Bluebird Bio Sickle Cell Disease Diagnosis and Treatment Introduction
11.9.4 Bluebird Bio Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
11.9.5 Bluebird Bio Recent Development
11.10 Prolong Pharmaceuticals
11.10.1 Prolong Pharmaceuticals Company Details
11.10.2 Prolong Pharmaceuticals Business Overview
11.10.3 Prolong Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Introduction
11.10.4 Prolong Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
11.10.5 Prolong Pharmaceuticals Recent Development
11.11 Modus Therapeutics
11.11.1 Modus Therapeutics Company Details
11.11.2 Modus Therapeutics Business Overview
11.11.3 Modus Therapeutics Sickle Cell Disease Diagnosis and Treatment Introduction
11.11.4 Modus Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
11.11.5 Modus Therapeutics Recent Development
11.12 Sangamo Biosciences
11.12.1 Sangamo Biosciences Company Details
11.12.2 Sangamo Biosciences Business Overview
11.12.3 Sangamo Biosciences Sickle Cell Disease Diagnosis and Treatment Introduction
11.12.4 Sangamo Biosciences Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
11.12.5 Sangamo Biosciences Recent Development
11.13 Bioverativ
11.13.1 Bioverativ Company Details
11.13.2 Bioverativ Business Overview
11.13.3 Bioverativ Sickle Cell Disease Diagnosis and Treatment Introduction
11.13.4 Bioverativ Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
11.13.5 Bioverativ Recent Development
11.14 Imara
11.14.1 Imara Company Details
11.14.2 Imara Business Overview
11.14.3 Imara Sickle Cell Disease Diagnosis and Treatment Introduction
11.14.4 Imara Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
11.14.5 Imara Recent Development
11.15 Ironwood Pharmaceuticals
11.15.1 Ironwood Pharmaceuticals Company Details
11.15.2 Ironwood Pharmaceuticals Business Overview
11.15.3 Ironwood Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Introduction
11.15.4 Ironwood Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
11.15.5 Ironwood Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diagnosis
Table 3. Key Players of Treatment
Table 4. Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Region (2020-2025)
Table 8. Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Region (2026-2031)
Table 10. Sickle Cell Disease Diagnosis and Treatment Market Trends
Table 11. Sickle Cell Disease Diagnosis and Treatment Market Drivers
Table 12. Sickle Cell Disease Diagnosis and Treatment Market Challenges
Table 13. Sickle Cell Disease Diagnosis and Treatment Market Restraints
Table 14. Global Sickle Cell Disease Diagnosis and Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Players (2020-2025)
Table 16. Global Top Sickle Cell Disease Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Diagnosis and Treatment as of 2024)
Table 17. Ranking of Global Top Sickle Cell Disease Diagnosis and Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Sickle Cell Disease Diagnosis and Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Headquarters and Area Served
Table 20. Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Product and Application
Table 21. Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Emmaus Medical Company Details
Table 47. Emmaus Medical Business Overview
Table 48. Emmaus Medical Sickle Cell Disease Diagnosis and Treatment Product
Table 49. Emmaus Medical Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 50. Emmaus Medical Recent Development
Table 51. Addmedica Company Details
Table 52. Addmedica Business Overview
Table 53. Addmedica Sickle Cell Disease Diagnosis and Treatment Product
Table 54. Addmedica Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 55. Addmedica Recent Development
Table 56. Gamida Cell Company Details
Table 57. Gamida Cell Business Overview
Table 58. Gamida Cell Sickle Cell Disease Diagnosis and Treatment Product
Table 59. Gamida Cell Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 60. Gamida Cell Recent Development
Table 61. GlycoMimetics Company Details
Table 62. GlycoMimetics Business Overview
Table 63. GlycoMimetics Sickle Cell Disease Diagnosis and Treatment Product
Table 64. GlycoMimetics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 65. GlycoMimetics Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Sickle Cell Disease Diagnosis and Treatment Product
Table 69. Pfizer Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Sickle Cell Disease Diagnosis and Treatment Product
Table 74. Novartis Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Global Blood Therapeutics Company Details
Table 77. Global Blood Therapeutics Business Overview
Table 78. Global Blood Therapeutics Sickle Cell Disease Diagnosis and Treatment Product
Table 79. Global Blood Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 80. Global Blood Therapeutics Recent Development
Table 81. Micelle BioPharma Company Details
Table 82. Micelle BioPharma Business Overview
Table 83. Micelle BioPharma Sickle Cell Disease Diagnosis and Treatment Product
Table 84. Micelle BioPharma Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 85. Micelle BioPharma Recent Development
Table 86. Bluebird Bio Company Details
Table 87. Bluebird Bio Business Overview
Table 88. Bluebird Bio Sickle Cell Disease Diagnosis and Treatment Product
Table 89. Bluebird Bio Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 90. Bluebird Bio Recent Development
Table 91. Prolong Pharmaceuticals Company Details
Table 92. Prolong Pharmaceuticals Business Overview
Table 93. Prolong Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Product
Table 94. Prolong Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 95. Prolong Pharmaceuticals Recent Development
Table 96. Modus Therapeutics Company Details
Table 97. Modus Therapeutics Business Overview
Table 98. Modus Therapeutics Sickle Cell Disease Diagnosis and Treatment Product
Table 99. Modus Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 100. Modus Therapeutics Recent Development
Table 101. Sangamo Biosciences Company Details
Table 102. Sangamo Biosciences Business Overview
Table 103. Sangamo Biosciences Sickle Cell Disease Diagnosis and Treatment Product
Table 104. Sangamo Biosciences Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 105. Sangamo Biosciences Recent Development
Table 106. Bioverativ Company Details
Table 107. Bioverativ Business Overview
Table 108. Bioverativ Sickle Cell Disease Diagnosis and Treatment Product
Table 109. Bioverativ Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 110. Bioverativ Recent Development
Table 111. Imara Company Details
Table 112. Imara Business Overview
Table 113. Imara Sickle Cell Disease Diagnosis and Treatment Product
Table 114. Imara Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 115. Imara Recent Development
Table 116. Ironwood Pharmaceuticals Company Details
Table 117. Ironwood Pharmaceuticals Business Overview
Table 118. Ironwood Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Product
Table 119. Ironwood Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)
Table 120. Ironwood Pharmaceuticals Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report


List of Figures
Figure 1. Sickle Cell Disease Diagnosis and Treatment Picture
Figure 2. Global Sickle Cell Disease Diagnosis and Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Type: 2024 VS 2031
Figure 4. Diagnosis Features
Figure 5. Treatment Features
Figure 6. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Application: 2024 VS 2031
Figure 8. Child Case Studies
Figure 9. Adult Case Studies
Figure 10. Sickle Cell Disease Diagnosis and Treatment Report Years Considered
Figure 11. Global Sickle Cell Disease Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Sickle Cell Disease Diagnosis and Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Region: 2024 VS 2031
Figure 14. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Players in 2024
Figure 15. Global Top Sickle Cell Disease Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Diagnosis and Treatment as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Sickle Cell Disease Diagnosis and Treatment Revenue in 2024
Figure 17. North America Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Sickle Cell Disease Diagnosis and Treatment Market Share by Country (2020-2031)
Figure 19. United States Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Sickle Cell Disease Diagnosis and Treatment Market Share by Country (2020-2031)
Figure 23. Germany Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Share by Region (2020-2031)
Figure 31. China Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Sickle Cell Disease Diagnosis and Treatment Market Share by Country (2020-2031)
Figure 39. Mexico Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Share by Country (2020-2031)
Figure 43. Turkey Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Emmaus Medical Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
Figure 47. Addmedica Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
Figure 48. Gamida Cell Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
Figure 49. GlycoMimetics Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
Figure 50. Pfizer Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
Figure 52. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
Figure 53. Micelle BioPharma Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
Figure 54. Bluebird Bio Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
Figure 55. Prolong Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
Figure 56. Modus Therapeutics Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
Figure 57. Sangamo Biosciences Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
Figure 58. Bioverativ Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
Figure 59. Imara Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
Figure 60. Ironwood Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies